Preparation and characterisation of ethylcellulose microparticles containing propolis

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 29, Issue 2, 2008, Pages 129-134

  Avanco G B ^a   Braschi, M L ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Brazilian propolis; Emulsification and solvent evaporation; Ethylcellulose; Microparticle characterisation; Optimisation

Indexed keywords

ALCOHOL; EMULSIFYING AGENT; ETHYL CELLULOSE; FLAVONOID; POLYSORBATE 80; PROPOLIS; SOLVENT;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DOSAGE FORM; EMULSION; EVAPORATION; MICROMORPHOLOGY; ODOR; PARTICLE SIZE; TASTE;

EID: 67049171322     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Amiet-Charpentier C, Gadille P, Digats B, Benoit JP. Microencapsulation and survival studies. JMicroencapsul 1998; 15(5):639-59.
2. Banskota AH, Nagaoka T, Sumioka LY, Tezuka Y, Awale S, Midorikawa K, Matsushige K, Kadota S. Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J Ethnopharmacol 2002; 80:67-73.
3. Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res 2001; 15:561-71.
4. Benita S, Benoit JP, Puisieux F, Thies C. Characterisation of drug loaded poly(d,l)-lactide microspheres. JPharm Sci 1984; 73:1721-4.
5. Billon A, Bataille B, Cassanas G, Jacob M. Development of spray-dried acetaminophen microparticles using experimental designs. Int JPharm 2000; 203:159-68.
6. Bodmeier R, McGiniry JW. Solvent selection in the preparation of poly (d,l)-lactide microspheres prepared by the solvent evaporation method. Int JPharm 1988; 43:179-86.
7. Bruschi ML, Cardoso MLC, Lucchesi MB, Gremiao MP. Gelatin microparticles containing propolis obtained by spray-drying technique: preparation and characterization. Int JPharm 2003; 264:45-55.
8. Bruschi ML, Jones DS, Panzeri H, Gremiao MPD, De Freitas O, Lara EHG. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rhcological, texlural, and mucoadhesive properties. JPharm Sci 2007; 96(8):2074-89.
9. Bruschi ML, Klein T, Lopes RS, Franco SL, Gremiao MPD. Contribuicao ao protocolo de controle de qualidade da propolis e de seus extratos. Rev Cienc Farm 2002; 23(2):289-306.
10. Bruschi ML, Lara EHG, Martins CHG, Vinholis AHC, Casemiro LA, Panzeri H, Gremiao MPD. Preparation and antimicrobial activity of gelatin microparticles containing propolis against oral pathogens. Drug Dev Ind Pharm 2006; 32:229-38.
11. Bruschi ML, Lopes RS, Franco SL, Gremiao MPD. In vitro release of propolis from gelatin microparticles prepared by spray-drying technique. Rev Cienc Farm 2004; 25(2):79-84.
12. Burdock GA. Review of the biological properties and toxicity of bee propolis (Propolis). Food Chem Toxicol 1998; 36:347-63.
13. Cavalier M, Benoit JP, Thies C. The formation and characterisation of hydrocortisone loaded poly(dl)lactide microspheres. JPharm Pharmacol 1986; 38:249-53.
14. Chandra R, Rustgi R. Biodegradable polymers. Prog Polym Sci 1998; 23:1273-335.
15. Dias SMD, Gomes RT, Santiago WK, Paula AMB, Cortes ME, Santos VR. Antifungal activity of commercial ethanolic and aqueous extracts of Brazilian propolis against Candida spp. Rev Cienc Farm BdsicaApl 2007; 28(3):259-63.
16. th.ed. Weinlieim: VCH Verlagsgssellschaft; 1990. p.575-88.
17. Ghisalberu' EL. Propolis: a review. Bee World 1979; 60:59- 80.
18. Hasan AS, Socha M, Lamprecht A, El Ghazouani F, Sapin A, Hoffmana M, Maincent P, Ubrich N. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm 2007; 344:53-61.
19. Heng PWS, Chan LW, Chow KT. Development of novel nonaqueous ethylcellulose gel matrices: rheological and mechanical characterization. Pharm Res 2005; 22(4):676- 84.
20. Homar M, Ubrich N, El Ghazouani F, Kristl J, Kerc J, Maincent P. Influence of polymers on the bioavailability of microencapsulated celecoxib. J Microencapsul 2007; 24(7):621-33.
21. Isla MI, Moreno MTN, Sampietro AR, Vattuone MA. Antioxidant activity of Argentine propolis extracts. J Ethnopharmacol 2001; 76:165-70.
22. Jones DS, Pearce KJ. An investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation method, hit J Pharm 1995; 118:199-205.
23. KartalM, Yildiz S, Kay a S, Kurucu S, Topgu G. Antimicrobial activity of propolis samples from two different regions of Anatolia. JEthnopharmacol 2003; 86:69-73.
24. Koo H, Gomes BPFA, RosalenPL, Ambrosano GMB, Park YK, Cury JA. In vitro antimicrobial activity of propolis and. Arnica montana against oral pathogens. Arch Oral Biol 2000; 45:141-8.
25. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999; 64:235-40.
26. Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 1995; 26:83-99.
27. Melliou E, Cliinou I. Chemical analysis and antimicrobial activity of Greek propolis. Planta Med 2004; 70(6):515-9.
28. Murad JM, Calvi SA, Soares AMVC, Bankova V, Sforcin JM. Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages agava&XParacoccidioides brasiliensis. J Ethnopharmacol 2002; 79:331-4.
29. Nagai T, Sakai M, Inoue R, Inoue H, Suzuki N. Antioxidative activities of some commercially honeys, royal jelly, and propolis. Food Chem 2001; 75:237-40.
30. Oliveira ACP, Shinobu CS, Longhini R, Franco SL, Svidzinski TIE. Ajitifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Mem InstOswaldo Cruz 2006; 101(5):493-7.
31. Ota C, Unterkircher C, Fantinato V, Shimizu MX Antifungical activity of propolis on different species of Candida. Mycoses 2001; 44:375-8.
32. Palmieri GF, Martell S, Lauri D, Wehrle P. Gelatin- acacia complex coacervation as a method for ketoprofen microencapsulation. Drug Dev Ind Pharm 1996; 22(9/10):951-7.
33. Pietta PG, Gardana C, Pietta AM. Analytical methods for quality control of propolis. Fitoterapia 2002; 73(Suppl l):7-20.
34. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from performed polymers. Drug DevlndPharm 1998; 24(12):1113-28.
35. Santos FA, Bastos EMA, Rodrigues PH, Uzeda MD, Carvalho MAR, De Farias LM, Moreira ES A. Susceptibility of Prevotella intermedia/Prevotella nigrescens (and Porphyromonas gingivalis) to propolis (bee glue) and other antimicrobial agents. Anaerobe 2002; 8:9-15.
36. Sawaya ACHF, Pahna AM, Caetano FM, Marcucci MC, Da Silva Cunha IB, Araujo CEP, Shimizu MT. Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions against species of Candida. LettApplMicrobiol 2002; 35:203-7.
37. Sforcin JM, Fernandes Jr A, Lopes CAM, Bankova V, Funari SRC. Seasonal effect on Brazilian propolis antibacterial activity. J Ethnopharmacol 2000; 73:243-9.
38. Song YS, Park E, Hur GM, Ryu YS, Kim YM, Jin C. Ethanol extract of propolis inhibits nitric oxide synthase gene expression and enzyme activity. J Ethnopharmacol 2002b; 80:155-61.
39. Song YS, Park E, Hur GM, Ryu YS, Lee YS, Lee JY, Kim YM, Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett 2002a; 175:53-61.
40. Tirkkonen S, Urtti A, Paronen P. Buffer controlled release of indomethacin from ethylcellulose microcapsules, lnt J Pharm 1995; 124:219-29.
41. Yamada T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethylcellulose and carboxymetliylethylcellulose. J Control Release 2001; 75:271-82.
42. Zhang ZY, Ping QN, Xiao B. Microencapsulation and characterization of tramadol-resin complexes. J Control Release 2000; 66:107-13.